Evaluation of Motor Imagery, Cognitive Function and Reaction Time in Children With Bronchiectasis

Atlas University

Status: Completed

Conditions: Bronchiectasis

Treatments: Other: Functional Capacity; Other: Ability of Motor Imagery; Other: Cognitive Functions; Other: Disease History; Other: Demographic Data; Other: Fear of movement; Other: Quality of Life; Other: Pulmonary Function Test; Other: Dyspnea Perception; Other: Reaction Time

Study type: Observational

Funder types: Other

Identifiers

NCT06630403

Aysenur Temizel Tombul

Details and patient eligibility

About

The aim of this study was to evaluate motor imagery ability, reaction time and cognitive function parameters in children with CF and non-CF bronchiectasis compared to healthy peers.

Full description

The main causes affecting exercise capacity in patients with bronchiectasis are restriction of tidal expiratory flow, dyspnea secondary to dynamic hyperinflation, changes in pulmonary mechanics, inadequate gas exchange and decreased skeletal muscle mass. Due to all these symptoms, exercise capacity decreases in patients with bronchiectasis and the importance of physical activity increases. . In addition to decreased exercise capacity in individuals with bronchiectasis, studies on the effect of motor imagery ability, which is considered as a mental exercise, have not been found. Inadequate blood supply to the brain and muscle dysfunction have been reported to cause cognitive damage and decreased reaction time in COPD patients.

Enrollment: 40 patients

Sex: All

Ages: 7 to 18 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Diagnosed with cystic or non-cystic bronchiectasis
• Being clinically stable
• Not having an exacerbation or infection
• Being between the ages of 7-18
• To be able to read and understand Turkish

Exclusion criteria

• Unstable concomitant cardiac, orthopedic or neurologic disease
• History of previous lung or liver transplantation
• History of acute exacerbation and/or hospitalization in the last 1 month
• Changes in medical treatment during the study period.

Trial design

40 participants in 2 patient groups

Children with Bronchiectasis Experiment Group

Description:

Children with bronchiectasis Participants will be required to sign an informed consent form before the evaluation. Assesment Methods: 1. Demographic data will be collected verbally. 2. The number of exacerbations in the last 1 year, hospitalization and medications used will be questioned. 3. Pulmonary Function Test will be applied. 4. Reaction time will be evaluated with the Nelson Hand-Foot Reaction Test. 5. Functional capacity of the patient will be evaluated with the 6 Minute Walk Test. 6. Dalhousie Dyspnea and Perceived Exertion Scale will be used to determine the level of dyspnea. 7. Quality of life will be assessed with the "Quality of Life Scale for Children". 8. Fear of movement will be assessed with the Tampa Kinesiophobia Scale. 9. Motor Imagery ability will be assessed with the Movement Imagery Questionnaire-3, Vividness of Movement Imagery. 10. Cognitive functions will be assessed with Trail Making Test and Stroop Test.

Treatment:

Other: Reaction Time

Other: Dyspnea Perception

Other: Pulmonary Function Test

Other: Quality of Life

Other: Fear of movement

Other: Demographic Data

Other: Cognitive Functions

Other: Ability of Motor Imagery

Other: Disease History

Other: Functional Capacity

Healthy Controls

Description:

Healthy Peers Participants will be required to sign an informed consent form before the evaluation. Assessment Methods: 1. Demographic data (age, height, weight, BMI) will be collected verbally via the assessment form. 2. Pulmonary Function Test will be applied. 3. Reaction time will be evaluated with the Nelson Hand-Foot Reaction Test. 4. Functional capacity of the patient will be evaluated with the 6 Minute Walk Test. 5. Dalhousie Dyspnea and Perceived Exertion Scale will be used to determine the level of dyspnea. 6. Quality of life will be assessed with the "Quality of Life Scale for Children". 7. Fear of movement will be assessed with the Tampa Kinesiophobia Scale. 8. Motor Imagery ability will be assessed with the Movement Imagery Questionnaire-3, Vividness of Movement Imagery. 9. Cognitive functions will be assessed with Trail Making Test and Stroop Test.

Treatment:

Other: Reaction Time

Other: Dyspnea Perception

Other: Pulmonary Function Test

Other: Quality of Life

Other: Fear of movement

Other: Demographic Data

Other: Cognitive Functions

Other: Ability of Motor Imagery

Other: Functional Capacity